Trehalose formulations and uses thereof
US12370204B2 · kind B2 · utility
0Cited by
19References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2020 |
| Grant date | Jul 29, 2025 |
| Priority date | — |
| Expiry date | Nov 21, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods of treating or alleviating one or more symptoms of mucopolysaccharidoses in a subject, via administering a trehalose formulation to the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.